RD162, a diarylthiohydantoin, is an orally active non-steroidal antiandrogen (NSAA). RD162 specifically binds to androgen receptor (AR). RD162 induces tumor regression in mouse models of castration-resistant human prostate cancer[1].
Molecular Weight:
476.45
Purity:
99.69
CAS Number:
[915087-27-3]
Formula:
C22H16F4N4O2S
Target:
Androgen Receptor
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted